Fasting Insulin
How much insulin your pancreas is producing in the fasted state to keep blood glucose normal.
The earliest warning sign of metabolic dysfunction — frequently elevated 5–10+ years before fasting glucose or HbA1c drift out of range. If you run one metabolic marker beyond glucose, run this.
Check a Fasting Insulin result against this range →
What Fasting Insulin actually measures — the analyte, and the assay
The analyte is insulin: a 51-amino-acid, two-chain peptide of about 5.8 kDa, held together by two interchain disulfide bridges. It is measured by sandwich immunoassay — a capture antibody on a solid phase, a labeled detection antibody, and a signal proportional to how much peptide bridged the two.
There is no international reference standard for the insulin immunoassay, and this is not a technicality. Seven commercial kits — four ELISA and three automated chemiluminescent — compared head to head showed substantial discrepancies, with relative standard deviations spanning 1.7% to 23.2%, and the authors concluded that existing reference materials are not commutable with patient serum, so they cannot be used to validate an immunoassay Rosli 2022.
The scale of the problem across real laboratories has been measured. Five pooled sera sent to 94 clinical laboratories produced an inter-laboratory coefficient of variation of 21.8% for insulin against 16.4% for C-peptide. Recalibrating everyone against standardized samples cut the inter-method CV for C-peptide from 24.5% to 5.7% — and for insulin only from 22.4% to 17.2% Zhou 2022. C-peptide can be harmonized and insulin, so far, cannot. Even antibody-free LC-MS/MS run across three laboratories carried a median interlaboratory imprecision of 22.2% for insulin against 13.4% for C-peptide Moradian 2024.
Two structural reasons sit underneath that. Antibodies raised against insulin cross-react to different degrees with proinsulin and the split proinsulins, which circulate at higher concentrations in exactly the insulin-resistant people being tested; and different kits detect the insulin analogs — glargine, lispro, aspart — to wildly different extents. Reference intervals therefore belong to the platform and not to the species Lorde 2023.
The practical rule: a fasting insulin is a number plus an analyzer. Comparing this year's 9 µIU/mL from one laboratory with last year's 6 from another is comparing two instruments whose disagreement on identical serum is around a fifth of the value.
Fasting Insulin: what changes the blood, and what only changes the reading
What changes the insulin in your blood — ranked:
- Visceral and hepatic fat. The dominant driver, and it moves insulin before it moves glucose by years. Hepatic triglyceride matters at concentrations far below the usual 5.56% steatosis threshold: in 2,331 prospectively recruited individuals the 95th percentile for liver fat in lean non-Asian-Indian participants was 1.85%, and hepatic triglyceride between 1.85% and 5.56% was already associated with higher insulin, higher triglycerides, higher urate and lower HDL cholesterol Petersen 2022. Being lean is not the same as having a lean liver.
- Hepatic insulin extraction. Around half of secreted insulin is cleared on its first pass through the liver, so a peripheral fasting insulin is secretion minus hepatic clearance, and fatty liver reduces the clearance term. Two people with identical pancreatic output can have materially different peripheral values Aizawa 2022.
- Growth-hormone-axis stimulation. Anything raising GH — MK-677 above all — reliably degrades insulin sensitivity and raises fasting insulin.
- Sleep restriction, measurably, after a single bad night.
- Fasting duration itself. Insulin's half-life is about 4 to 6 minutes; the value is a near-instantaneous read on the last hour, so a 9-hour fast and a 14-hour fast are different measurements.
- Recent exercise, which lowers it for up to 48 hours, and acute stress or illness, which raise it.
What changes only the reading:
- Which kit ran it — a larger term than most of the physiology above Rosli 2022 Zhou 2022.
- Insulin antibodies. Anti-insulin antibodies form immune complexes that different immunoassays handle differently; a published case of transient hypoglycemia showed varying degrees of interference from insulin-antibody complexes across three insulin immunoassays in the same patient Teoli 2024, and insulin autoimmune syndrome produces spectacularly high apparent insulin with normal beta-cell behavior Lin 2023.
- Injected insulin and insulin analogs, detected inconsistently — the reason C-peptide exists as a separate test.
- Hemolysis. Red cells carry insulin-degrading enzyme, so a hemolyzed or slowly separated sample reads falsely low. This is a preanalytical loss with no biological meaning at all.
- Biotin, on any streptavidin-based platform, where high-dose supplementation displaces the capture chemistry Balzer 2023.
Reference interval or decision threshold — which kind of number Fasting Insulin is
A reference interval, and one of the least useful on any lab report. A quoted 2.6–24.9 µIU/mL is the central 95% of whoever that laboratory measured — a population in which, by any contemporary estimate, a large minority are already insulin resistant. The upper limit is therefore a description of how common the problem is, not a boundary of health. It is the clearest case on the whole site of 'in range' and 'normal' being different claims.
It is also not portable. With an inter-laboratory CV around 22% Zhou 2022, an interval printed by one laboratory is an interval for one instrument, and reference intervals that vary between assays are a documented source of misdiagnosis in endocrine testing Lorde 2023.
HOMA-IR inherits every one of those problems and adds a constant. HOMA-IR is fasting glucose in mg/dL multiplied by fasting insulin in µIU/mL, divided by 405 — and the insulin term is the unstandardized one. A HOMA-IR cut-off of 2.0 is therefore a platform-specific cut-off masquerading as a universal one. Use it longitudinally against your own previous value on the same analyzer, not as a line to cross.
No fasting insulin threshold has ever been validated against a hard outcome. Targets of under 8, or under 5, come from reasoning about where risk is continuous, exactly like the HbA1c optimum. That is a legitimate way to set a goal and it is not the same kind of number as a diagnostic threshold.
How you would know your Fasting Insulin was wrong — and when to redraw
The molecule clears in minutes, so the retest interval is set by the intervention, not the analyte. With a half-life of 4 to 6 minutes, a fasting insulin is a snapshot of the last hour, and its day-to-day within-person variation is large — far larger than HbA1c's. A single value is a weak measurement; two values a fortnight apart are a much better one.
Conditions that must match, or you are comparing instruments: the same laboratory and the same platform Rosli 2022; the same fasting duration, 9 to 12 hours; no training in the preceding 24 to 48 hours; no acute illness; no biotin for at least 48 hours Balzer 2023; and a sample separated promptly, because delayed separation destroys insulin.
What would have to change for the retest to mean something. A fall of less than about a fifth is inside the range two laboratories disagree by on identical serum Zhou 2022. A real improvement in insulin sensitivity should carry its neighbors: triglycerides down, HDL up, ALT down, SHBG up in men, waist down. Fasting insulin moving alone, with triglycerides and ALT flat, is more likely to be the assay or the fast than the pancreas.
How you would know the value was wrong. An implausibly high insulin with a normal glucose and no hypoglycemia is the classic signature of antibody interference, and the confirmatory test is a simultaneous C-peptide: endogenous insulin and C-peptide are secreted in equal molar amounts, so a high insulin with a low or ordinary C-peptide points at exogenous insulin or at an interfering antibody rather than at a pancreas Teoli 2024 Lin 2023. An implausibly low insulin with a normal C-peptide points at hemolysis or a slow spin.
What Fasting Insulin cannot tell you
It cannot separate secretion from clearance. A peripheral fasting insulin is what survived the liver, and hepatic extraction is itself altered by hepatic fat Aizawa 2022. Two people with the same number can have different pancreases.
It cannot tell your insulin from injected insulin. That is C-peptide's job, and no fasting insulin answers it Teoli 2024.
A fasting value misses the postprandial phase, which moves first. Hyperinsulinemia after a meal precedes fasting hyperinsulinemia, which precedes dysglycemia, which precedes a raised HbA1c. Testing only fasting insulin catches the second of four stages, which is still far earlier than HbA1c and is not the earliest.
A single value is a weak measurement given both the biological variation and the analytical variation Zhou 2022 Moradian 2024.
It does not measure insulin sensitivity. It is a proxy for it under the assumption that glucose is normal, and the reference method — the hyperinsulinemic-euglycemic clamp — is a research procedure nobody is running on you.
The wrong inference readers actually draw is that a low fasting insulin certifies metabolic health. It does not, in two situations that matter here: a lean person with a fatty liver can carry an unremarkable fasting insulin alongside a hepatic triglyceride content already in the range associated with higher triglycerides and urate and lower HDL Petersen 2022; and a genuinely low insulin alongside a rising glucose is beta-cell failure, which is the opposite of good news.
Sources read for these sections
- Rosli N, et al. Measurement comparability of insulin assays using conventional immunoassay kits. Journal of Clinical Laboratory Analysis 2022 · PMID 35622611
- Zhou W, et al. Current Status of Serum Insulin and C-Peptide Measurement in Clinical Laboratories: Experience from 94 Laboratories in China. Annals of Laboratory Medicine 2022 · PMID 35177563
- Moradian A, et al. Interlaboratory Comparison of Antibody-Free LC-MS/MS Measurements of C-peptide and Insulin. Clinical Chemistry 2024 · PMID 38549041
- Teoli J, et al. When discordant insulin and C-peptide levels lead to a medical diagnosis in a patient with transient hypoglycemia: Varying degrees of interference of insulin-antibody complexes on three insulin immunoassays. Heliyon 2024 · PMID 39071705
- Lin M, et al. Insulin Autoimmune Syndrome: A Systematic Review. International Journal of Endocrinology 2023 · PMID 36844104
- Balzer AHA, et al. An Analysis of the Biotin-(Strept)avidin System in Immunoassays: Interference and Mitigation Strategies. Current Issues in Molecular Biology 2023 · PMID 37998726
- Petersen KF, et al. Ethnic and sex differences in hepatic lipid content and related cardiometabolic parameters in lean individuals. JCI Insight 2022 · PMID 35167495
- Aizawa T, et al. Hepatic Steatosis and High-Normal Fasting Glucose as Risk Factors for Incident Prediabetes. Journal of the Endocrine Society 2022 · PMID 35958436
- Lorde N, et al. Impact of Variation between Assays and Reference Intervals in the Diagnosis of Endocrine Disorders. Diagnostics (Basel) 2023 · PMID 37998589
The plan of attack
In this order. Most people start at step four, which is why they change five things at once and learn nothing.
- Confirm the number is real
Hemolysis (burst red cells). Red cells rupturing in the tube spill their contents into the serum. Potassium, LDH, AST and magnesium are far higher inside cells than outside, so a hemolyzed sample reports them falsely high. Caused by a difficult draw, a narrow needle, or shaking the tube. The lab usually flags it. If your result is odd and the report mentions hemolysis, that is your answer — repeat the draw. - Read it with its partner
Fast 9–12h. This is the marker that catches problems while they're still fully reversible. Draw it alongside: HbA1c (Hemoglobin A1c), Comprehensive Metabolic Panel (CMP), SHBG (Sex Hormone-Binding Globulin). - Work out which direction is yours
If it's high — Insulin resistance. Drives fat storage, inflammation, low SHBG, high triglycerides, and eventually type 2 diabetes. - Fix it in this order
Nutrition. Fat loss — especially visceral — is the dominant lever. Reduce refined carbohydrate and added sugar, prioritize protein and fiber, and consider carbohydrate timing around training. A 10-minute walk after meals measurably blunts glucose and insulin excursions.
Lifestyle. Resistance training builds the glucose sink — muscle is the primary disposal site. Add zone-2 cardio, post-meal walks, and fix sleep: even one night of poor sleep measurably worsens insulin sensitivity.
Supplements. Berberine (comparable to metformin in some trials), myo-inositol (particularly strong evidence in PCOS), magnesium, chromium, alpha-lipoic acid, and adequate vitamin D.
Hormones. Metformin and GLP-1 receptor agonists (semaglutide, tirzepatide, retatrutide) substantially improve insulin sensitivity. Correct low testosterone in men and treat PCOS in women — both feed the cycle.
Compounds. Anyone running MK-677 must track fasting insulin and HbA1c — GH-axis stimulation reliably degrades insulin sensitivity. GLP-1s dramatically improve it. Use with fasting glucose to calculate HOMA-IR = (glucose × insulin) / 405; optimal is under 1.5.
Work down the list, not across it. Adding a compound on top of an unfixed diet is why generic protocols fail. - Retest
Every 3–6 months, or 8–12 weeks after an intervention. Change one thing at a time, or the retest can't tell you which thing worked.
How to fix it
📚 Matthews DR et al., Diabetologia 1985 — HOMA-IR. Crofts C et al., Diabesity 2016 — hyperinsulinemia precedes dysglycemia.
This page can tell you what could have made your Fasting Insulin wrong. It cannot tell you whether it did.
Everything above is free and stays free — the assay, what changes the reading rather than the blood, the retest window and the sources. What no page can do is look at your draw: which laboratory ran it, at what hour, what you were taking that week, and what else was flagged beside it. Every one of those changes the answer, and none of them is on any page. Bringing a real result to people who know that list is what the members' area is for.
Bring your result — $10/mo →🩸 Test your Fasting Insulin
Order directly through Marek Diagnostics — no doctor's visit needed, drawn at any Quest location in the US. Code CAMERON applies 10% off automatically.
Order this test — 10% off → Browse all 103 markers →What Fasting Insulin is usually tested alongside
One marker is a data point. These panels add the markers that make Fasting Insulin interpretable, name why each is on the list, and load the set into your cart at 10% off.
includes this + 7 more markers — Weight that won't shift, energy crashes after meals, expanding waistline, family history of diabetes, or a fasting glucose that's crept into the 90s.
includes this + 8 more markers — Anyone over 30, anyone with a family history of early heart disease, or anyone who's been told their cholesterol is 'fine' and wants to know what that actually means.
includes this + 9 more markers · built for women — Irregular or absent periods, acne, unwanted hair growth, scalp thinning, difficulty losing weight, or you've been told 'probably PCOS' without a workup.
What people use Fasting Insulin to decide
Nobody orders a test for its own sake. Fasting Insulin is on the test list for these pathways — each one links to what the pathway claims, and what its test list is read for before you spend anything on it.
High fasting insulin with a normal glucose is the classic pre-diabetic picture, and it means appetite is being driven hormonally rather than by willpower. That is the strongest argument for this pathway. If insulin is genuinely low and you still can't stop eating, the driver is behavioral or psychological and no incretin will fix it.
IGF-1 is the only honest read on whether a GH protocol is doing anything — GH itself is pulsatile and a single draw is close to meaningless. Track fasting glucose and insulin alongside, because the most predictable cost of this pathway is insulin resistance and it arrives quietly.
Autophagy is suppressed by nutrient abundance, so insulin and HbA1c are the levers you can actually see. Roughly 40% of people cannot produce Urolithin A from food at all, which is the argument for supplementing the metabolite.
This is the pathway with the clearest test. Fasting insulin above roughly 8 µIU/mL, triglyceride:HDL above 2, or raised uric acid all point at insulin resistance — and if that's your picture, this pathway outranks every other one on the page for you specifically.
Fasting Insulin is also on the test list for these, where it narrows the picture rather than settling it:
AMPK activation & cellular fuel sensing · Hepatic fat & fatty liver · Glucose disposal, absorption & the post-meal curve · Incretin & satiety signaling
What moves your Fasting Insulin
14 compounds in the Vault have a documented effect on this marker, or are a reason to have measured it first:
Browse all 278 compounds & 371 supplements →
Would you feel it? Symptoms Fasting Insulin helps explain
People search for how they feel, not for a marker. These are the complaints where this one is worth checking, and whether it is first-line or a follow-up.
Why your Fasting Insulin might be wrong
Most abnormal results are interference, not disease. Check these before you change anything. Each says whether the number is wrong (repeat it), badly timed (redraw it), or real with a cause.
Rises after eating, so a non-fasted draw measures your breakfast rather than your baseline.
Draw fasted, 10–12 hours, water only.
Insulin responds within minutes to eating. Even a coffee with milk the morning of the draw will move it, and it is far more sensitive to this than glucose.
12 hours fasted, water only. This marker is unusually unforgiving.
Red cells rupturing in the tube spill their contents into the serum. Potassium, LDH, AST and magnesium are far higher inside cells than outside, so a hemolyzed sample reports them falsely high. Caused by a difficult draw, a narrow needle, or shaking the tube.
The lab usually flags it. If your result is odd and the report mentions hemolysis, that is your answer — repeat the draw.
Improves insulin sensitivity acutely for up to 48 hours, so a draw the morning after training flatters the number.
Consistent conditions matter more than good ones — same routine every retest.
What Fasting Insulin means in combination
One marker tells you a little; combinations tell you the story. These are the named patterns this one takes part in.
The classic polycystic ovary syndrome pattern, with insulin resistance as the usual engine driving androgen excess.
Treating the insulin resistance often improves everything downstream — cycles, acne, hair. Myo-inositol has strong evidence; also fat loss, resistance training, and metformin or GLP-1 where appropriate. Work with a provider.
Classic compensated insulin resistance. Your pancreas is working overtime to keep glucose normal — so the standard screening tests look fine while the underlying problem builds.
This is the most reversible stage. Fat loss, resistance training, post-meal walks, fiber, reduced refined carbohydrate. Consider berberine or inositol; metformin/GLP-1 if clinically appropriate.
Insulin resistance reduces uric acid excretion by the kidney. So a raised urate is very often a metabolic signal arriving before anyone has a painful toe.
Treat the insulin resistance and urate usually follows. Cut fructose and alcohol (beer especially). Do not start urate-lowering drugs off one reading — that is a clinical decision with its own trade-offs.
C-peptide confirms the pancreas is still producing well, so this is a receptor-side problem rather than a production one. That distinction changes what actually helps.
Everything that improves insulin sensitivity applies and is likely to work: resistance training, fat loss, sleep, fiber, post-meal walking. A genuinely low C-peptide is the opposite situation and needs a clinician promptly.
What to test next
These put Fasting Insulin in context — each with its own full breakdown.
Frequently asked questions
2.6–24.9 µIU/mL — a range so wide it's nearly useless, because it includes many people with significant insulin resistance. Ranges vary by laboratory and assay — always compare to the range printed on your own report.
<8 µIU/mL; <5 µIU/mL is excellent. The clearest example in all of bloodwork that 'in range' ≠ healthy.
Insulin resistance. Drives fat storage, inflammation, low SHBG, high triglycerides, and eventually type 2 diabetes.
Favorable when glucose is normal. Low insulin with high glucose suggests inadequate insulin production (type 1/late type 2) — that's a medical evaluation.
You can order Fasting Insulin directly through Marek Diagnostics without a doctor's visit — drawn at any Quest Diagnostics location in the US. Code CAMERON applies 10% off automatically.
Where this goes next
This page is the free framework. The protocol itself — the dosing, the order to correct things in, the week-by-week schedule and what to retest — is a lesson inside Skool.